Principles of multiparametric optimization for phospholipidomics by 31P NMR spectroscopy

Biophysical Reviews

Volumn 5, Issue 4, 2013, Pages 295-304

  Lutz, Norbert W ^a   Cozzone, Patrick J ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Multiparametric optimization; Phospholipid quantification; Phospholipidomics; Spectral resolution; Tissue extracts

Indexed keywords

CHELATING AGENT; FATTY ACID; ORGANIC SOLVENT; PHOSPHOLIPID; TISSUE EXTRACT;

DISSOLUTION; HUMAN; LIPID ANALYSIS; NONHUMAN; PH; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROCESS OPTIMIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TEMPERATURE;

EID: 84893009387     PISSN: 18672450     EISSN: 18672469     Source Type: Journal    
DOI: 10.1007/s12551-013-0105-3     Document Type: Review

References (36)

1. Aoki J, Inoue A, Okudaira S (2008) Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781(9): 513-518.
2. Bauer A, Schumann A, Gilbert M, Wilhelm C, Hengstler JG, Schiller J, Fuchs B (2009) Evaluation of carbon tetrachloride-induced stress on rat hepatocytes by 31P NMR and MALDI-TOF mass spectrometry: lysophosphatidylcholine generation from unsaturated phosphatidylcholines. Chem Phys Lipids 159(1): 21-29.
3. Beloueche-Babari M, Chung YL, Al-Saffar NM, Falck-Miniotis M, Leach MO (2010) Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy. Br J Cancer 102(1): 1-7.
4. Branca M, Culeddu N, Fruianu M, Serra MV (1995) 31P nuclear magnetic resonance analysis of phospholipids in a ternary homogeneous system. Anal Biochem 232(1): 1-6.
5. Cui Z, Thomas MJ (2009) Phospholipid profiling by tandem mass spectrometry. J Chromatogr B 877: 2709-2715.
6. Dannenberger D, Suss R, Teuber K, Fuchs B, Nuernberg K, Schiller J (2010) The intact muscle lipid composition of bulls: an investigation by MALDI-TOF MS and 31P NMR. Chem Phys Lipids 163(2): 157-164.
7. Delikatny EJ, Cooper WA, Brammah S, Sathasivam N, Rideout DC (2002) Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria. Cancer Res 62: 1394-1400.
8. Deschamps FS, Gaudin K, Lesellier E, Tchapla A, Ferrier D, Baillet A, Chaminade R (2001) Response enhancement for the evaporative light scattering detection for the analysis of lipid classes and molecular species. Chromatographia 54: 607-611.
9. Farrar TC, Becker ED (1971) Pulse and Fourier transform NMR: introduction to theory and methods. Academic, New York.
10. Fuchs B, Schiller J, Wagner U, Hantzschel H, Arnold K (2005) The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. Clin Biochem 38(10): 925-933.
11. Fuchs B, Schiller J, Cross MA (2007a) Apoptosis-associated changes in the glycerophospholipid composition of hematopoietic progenitor cells monitored by 31P NMR spectroscopy and MALDI-TOF mass spectrometry. Chem Phys Lipids 150(2): 229-238.
12. Fuchs B, Schiller J, Suss R, Schurenberg M, Suckau D (2007b) A direct and simple method of coupling matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) to thin-layer chromatography (TLC) for the analysis of phospholipids from egg yolk. Anal Bioanal Chem 389(3): 827-834.
13. Glunde K, Jacobs MA, Bhujwalla ZM (2006) Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn 6(6): 821-829.
14. Gómez-Fernández JC, Villalaín J (1998) The use of FT-IR for quantitative studies of the apparent pKa of lipid carboxyl groups and the dehydration degree of the phosphate group of phospholipids. Chem Phys Lipids 96: 41-52.
15. Günther H (1995) NMR spectroscopy. Basic principles, concepts, and applications in chemistry, 2nd edn. Wiley, Chichester.
16. Ibrahim H, Caudron E, Kasselouri A, Prognon P (2010) Interest of fluorescence derivatization and fluorescence probe assisted post-column detection of phospholipids: a short review. Molecules 15(1): 352-373. doi: 10. 3390/molecules15010352.
17. Jakop U, Fuchs B, Suss R, Wibbelt G, Braun B, Muller K, Schiller J (2009) The solubilisation of boar sperm membranes by different detergents-a microscopic, MALDI-TOF MS, (31)P NMR and PAGE study on membrane lysis, extraction efficiency, lipid and protein composition. Lipids Health Dis 8: 49.
18. London E, Feigenson GW (1979) Phosphorus NMR analysis of phospholipids in detergents. J Lipid Res 20(3): 408-412. Comment: Seminal paper describing the analysis of phospholipids by (31)P NMR spectroscopy. This pioneering work has been cited by many authors working on the ongoing development of this method.
19. Lopez O, de la Maza A, Coderch L, Lopez-Iglesias C, Wehrli E, Parra JL (1998) Direct formation of mixed micelles in the solubilization of phospholipid liposomes by Triton X-100. FEBS Lett 426(3): 314-318.
20. Lutz NW (2005) Phospholipidomics by means of 31P NMR spectroscopy can be used to characterize metabolic phenotypes of cancer cells sensitive or resistant to oxidative stress and apoptosis. In: 9th International Conference Eicosanoids & Other Bioactive Lipids in Cancer, Inflammation & Related Diseases, San Francisco, CA, USA, September 11-14, 2005. http://bioactivelipidsconf. wayne. edu/2005-Conference Comment: First documented use of the term "phospholipidomics".
21. Lutz NW, Cozzone PJ (2010a) Multiparametric optimization of (31)P NMR spectroscopic analysis of phospholipids in crude tissue extracts. 1. Chemical shift and signal separation. Anal Chem 82(13): 5433-5440 Comment: This paper and the subsequent reference contain a very detailed description of the theoretical background of the optimization of phospholipid analysis by (31)P NMR spectroscopy. In addition, all procedures are fully described. In particular, the Supplementary Informations (SI) to these articles provide extensive complementary information and a comprehensive data base (75 pages for both SIs combined).
22. Lutz NW, Cozzone PJ (2010b) Multiparametric optimization of (31)P NMR spectroscopic analysis of phospholipids in crude tissue extracts. 2. Line width and spectral resolution. Anal Chem 82(13): 5441-5446.
23. Lutz NW, Cozzone PJ (2013) Phospholipidomics by phosphorus nuclear magnetic resonance spectroscopy of tissue extracts. In: Lutz NW, Sweedler JV, Wevers RA (eds) Methodologies for metabolomics. Cambridge University Press, New York, pp 377-414.
24. Merchant TE, Minsky BD, Lauwers GV, Diamantis PM, Haida T, Glonek T (1999) Esophageal cancer phospholipids correlated with histopathologic findings: a 31P NMR study. NMR Biomed 12: 184-188. Comment: Glonek's group played a crucial role in applying phospholipid analysis to biologically relevant questions, notably to cancer research.
25. Metz KR, Dunphy LK (1996) Absolute quantitation of tissue phospholipids using 31P NMR spectroscopy. J Lipid Res 37: 2251-2265.
26. Muller M, Schiller J, Petkovic M, Zschornig O, Arnhold J, Arnold K (2004) Analysis of enzymatically generated phosphoinositides by (31)P nuclear magnetic resonance spectroscopy. Anal Biochem 330(1): 167-171.
27. Pearce JM, Komoroski RA (1993) Resolution of phospholipid molecular species by 31P NMR. Magn Reson Med 29: 724-731. Comment: Very significant early work highlighting the importance of improved resolution of phospholipid (31)P NMR spectra.
28. Peterson BL, Cummings BS (2006) A review of chromatographic methods for the assessment of phospholipids in biological samples. Biomed Chromatogr 20(3): 227-243.
29. Puppato A, DuPre DB, Stolowich N, Yappert MC (2007) Effect of temperature and pH on 31P nuclear magnetic resonances of phospholipids in cholate micelles. Chem Phys Lipids 150(2): 176-185.
30. Renner C, Kessler B, Oesterhelt D (2005) Lipid composition of integral purple membrane by 1H and 31P NMR. J Lipid Res 46(8): 1755-1764.
31. Sanders JKM, Hunter BK (1993) Modern NMR spectroscopy. Oxford University Press, Oxford.
32. Schiller J, Arnold K (2002) Application of high resolution 31P NMR spectroscopy to the characterization of the phospholipid composition of tissues and body fluids-a methodological review. Med Sci Monit 8(11): MT205-MT222.
33. Schiller J, Zschornig O, Petkovic M, Muller M, Arnhold J, Arnold K (2001) Lipid analysis of human HDL and LDL by MALDI-TOF mass spectrometry and (31)P-NMR. J Lipid Res 42(9): 1501-1508.
34. Solivera J, Cerdan S, Pascual JM, Barrios L, Roda JM (2009) Assessment of 31P-NMR analysis of phospholipid profiles for potential differential diagnosis of human cerebral tumors. NMR Biomed 22(6): 663-674.
35. Sullentrop F, Moka D, Neubauer S, Haupt G, Engelmann U, Hahn J, Schicha H (2002) 31P NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma. NMR Biomed 15(1): 60-68.
36. Tome ME, Lutz NW, Briehl MM (2003) Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI7. 2 cells. Biochim Biophys Acta 1642: 149-162.